{"nct_id":"NCT06211036","title":"Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-06-05","start_date_type":"ACTUAL","primary_completion_date":"2027-07-05","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}